GENE ONLINE|News &
Opinion
Blog

Ruchi Jhonsa

WRITTEN BY Ruchi Jhonsa

How Does Moderna’s mRNA Vaccine Measure Up to Pfizer’s?
2020-11-16
Moderna’s mRNA-Based Cancer Vaccine Shows Encouraging Results in Phase 1 Trial
2020-11-13
Hot Pursuit for Antibody Drug Conjugates Continue as Merck Acquires VelosBio
2020-11-06
Spotlight: An AI Method to Determine Asymptomatic COVID-19 Patients
2020-11-05
Why is PerkinElmer Buying Horizon Discovery?
2020-11-02
FMI’s Liquid Biopsy Test Adds 3 Companion Diagnostic Indications for Advanced Ovarian, Breast and Lung Cancers
2020-10-30
Pfizer Expands Antibacterial Portfolio by Acquiring Antibiotic Drug Maker
2020-10-28
Is Bayer’s Entry to the Gene Therapy Market Worth it’s Investment?
2020-10-27
The Future of CRISPR: Three Areas The Nobel Prize Winning Tech Will Be Most Impactful
2020-10-25
Genentech Looks to Strengthen Drug Discovery by Collaborating With This Stanford Spinout
2020-10-21
With its AAT Deficiency Therapy Biting the Dust, Vertex Pins Hope on Second Drug
2020-10-16
Harvard Spinout Bags $1.8 Billion Worth Gene Therapy Deal with Roche
2020-10-15
After AZ, Another Big Pharma Halts COVID-19 Vaccine Trial Due to Patient Illness
2020-10-13
Amgen’s KRAS G12C Inhibitor Impresses in Phase 2 NSCLC Trial
2020-10-09
CRISPR Pioneers Bag 2020 Nobel Prize in Chemistry
2020-10-07
1 … 3 4 5 6 7 … 13
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top